AxonDAO Introduces AVoice Leading the Way in Biometric AI Voice Collection

FOR IMMEDIATE RELEASE
Cheyenne, WY, June 12, 2024 – Axon DAO LLC, based in Wyoming, is thrilled to introduce A+Voice, an innovative research platform that focuses on monitoring vocal biomarkers. This cutting-edge platform is a powerful tool for detecting and tracking conditions such as Alzheimer’s, Parkinson’s, dementia, PTSD, and Huntington’s Disease at an early stage.
The evaluation of vocal biomarkers can also provide insights into fatigue, energy levels, and could potentially revolutionize safety monitoring across various professions, including commercial truck drivers, car operators, and heavy machinery workers. Axon DAO has plans to further develop their models to identify biomarkers that indicate changes in anxiety, stress, and mood.
Utilizing decentralized ledger technology, zero-knowledge security, and other advanced tools, Axon DAO empowers research participants to access, own, and manage their health data. By fostering community engagement and transparent data collection, Axon DAO facilitates large-scale research studies, surpassing traditional methods employed by both academia and industry.
Introducing A+Voice
A+Voice represents Axon DAO’s groundbreaking AI voice collection and analysis software. This platform integrates a reward system to gather high-quality voice data, which undergoes rigorous quality assessment and analysis. Through blockchain technology, A+Voice timestamps, anonymizes, and processes data into patterned AI processes while adhering to strict HIPAA and ISO 27001 compliance standards for secure data management.
Strategic Partnerships and Achievements
Axon DAO's recent acceptance into NVIDIA’s Inception Program on October 27, 2023, underscores its commitment to excellence. In March, the Axon DAO team presented its vision at NVIDIA’s GTC event in San Jose, California. Strategic collaborations have been instrumental in the launch of A+Voice:
NVIDIA: Enabling the scalability of A+Voice and products using cutting-edge GPU processors.
639 Solar: Hosting Axon DAO’s DeSci Research Toolkit and Computational Engine in one of the world’s largest solar-powered data centers.
DataLake: Providing industry-standard consent management, including user rights to retract personal data access.
Axon DAO's Vision and Market Potential
Axon DAO is dedicated to fostering human connections and advancing scientific research through biometric data. The personal data market, currently valued at $1.61 trillion, is projected to reach $17.06 trillion by 2029 with the incorporation of high-quality biometric data.
Axon DAO on Mario’s Nawfal Roundtable X Account
Axon DAO will be featured on Mario’s Roundtable X account this Thursday, June 13th, at 12:00 PM EST. Join the session to gain insights into Axon DAO’s groundbreaking initiatives and its vision for the future of decentralized science.
About $AXGT
Axon DAO’s governance token, $AXGT, is an Ethereum-based token with connections to Arbitrum and BASE. $AXGT is currently undergoing a security audit by Certik. The token is available on UniSwap and will be submitted for listing on major Tier 1 exchanges to enhance accessibility. $AXGT’s utility includes voting on funded projects, project submission, and data collection within the Axon DAO ecosystem. The current market cap stands at $44.7M, with a fully diluted valuation (FDV) of $271M, and is priced at $0.271 per $AXGT.
For more information, please visit axondao.io.
About Axon DAO
Axon DAO is a decentralized autonomous organization focused on fostering, funding, and supporting scientific research using biometric data. By leveraging blockchain and AI technologies, Axon DAO aims to transform how biometric data is collected, processed, and utilized for scientific progress.
Media Contact:
[email protected]
[email protected]
This press release serves as a source of information. Readers are advised to conduct their own research before making any decisions related to the company or its services. Bitcoin.com bears no responsibility for any damages or losses resulting from the use of or reliance on the content, products, or services mentioned in this press release.